Yupingfeng San Inhibits NLRP3 Inflammasome to Attenuate the Inflammatory Response in Asthma Mice

Yupingfeng San Inhibits NLRP3 Inflammasome to Attenuate the Inflammatory Response in Asthma Mice

Yupingfeng San (YPFS) is a representative Traditional Chinese Medicine (TCM) formula with accepted therapeutic effect on Asthma. However, its action mechanism is still obscure. In this study, we used network pharmacology to explore potential mechanism of YPFS on asthma. Nucleotide-binding oligomeriz...

Full description

Bibliographic Details
Main Authors:	Xue Liu, Jiawen Shen, Danping Fan, Xuemei Qiu, Qingqing Guo, Kang Zheng, Hui Luo, Jun Shu, Cheng Lu, Ge Zhang, Aiping Lu, Chaoying Ma, Xiaojuan He
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-12-01
Series:	Frontiers in Pharmacology
Subjects:	Yupingfeng San asthma network pharmacology NLRP3 inflammasome inflammation
Online Access:	http://journal.frontiersin.org/article/10.3389/fphar.2017.00944/full

Similar Items

Yupingfeng polysaccharide promote the growth of chickens via regulating gut microbiota
by: Yuling Guan, et al.
Published: (2024-02-01)

Effects of Yupingfeng Polysaccharides as Feed Supplement on Immune Function and Intestinal Microbiome in Chickens
by: Wendan Zheng, et al.
Published: (2023-11-01)

Effect of Yupingfeng granules combined with glucocorticoid on eosinophil infiltration and inflammatory factors of lavage fluid in nasal secretion of patients with allergic rhinitis
by: Rong HU, et al.
Published: (2023-11-01)

Adjuvant treatment with yupingfeng granules for recurrent respiratory tract infections in children: A systematic review and meta-analysis
by: Lu Zhang, et al.
Published: (2022-12-01)

Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study
by: Ma JF, et al.
Published: (2018-10-01)

Safety and efficacy of Yupingfeng granules in children with recurrent respiratory tract infection: A randomized clinical trial
by: Baoping Xu, et al.
Published: (2022-06-01)

Effect of YuPingFeng granules on clinical symptoms of stable COPD: study protocol for a multicenter, double-blind, and randomized controlled trial
by: Ruifeng Chen, et al.
Published: (2024-01-01)

Therapeutic Potential of Pien Tze Huang on Experimental Autoimmune Encephalomyelitis Rat
by: Xuemei Qiu, et al.
Published: (2018-01-01)

Cost-Effectiveness Analysis of the TCM “Yupingfeng Granules” in the Treatment of Acute Exacerbations of COPD Based on a Randomized Clinical Trial
by: Hu M, et al.
Published: (2022-09-01)

Supplementation of Yupingfeng polysaccharides in low fishmeal diets enhances intestinal health through influencing the intestinal barrier, immunity, and microflora in Macrobrachium rosenbergii
by: Mingyang Liu, et al.
Published: (2024-11-01)

The efficacy and safety of Yupingfeng Powder with variation in the treatment of allergic rhinitis: Study protocol for a randomized, double-blind, placebo-controlled trial
by: Pui Kuan Cheong, et al.
Published: (2022-12-01)

NLRP3, NLRP6, and NLRP12 are inflammasomes with distinct expression patterns
by: Bo Wei, et al.
Published: (2024-07-01)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
by: Yang Gyun Kim, et al.
Published: (2019-11-01)

The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
by: Yao Shen, et al.
Published: (2022-08-01)

Tanreqing injection inhibits dengue virus encephalitis by suppressing the activation of NLRP3 inflammasome
by: Hefei Huang, et al.
Published: (2024-02-01)

Gubentongluo decoction alleviates NLRP3 inflammasome in IgAN cell model
by: Wei Meng, et al.
Published: (2023-12-01)

Fantastic voyage: The journey of NLRP3 inflammasome activation
by: Xiangyong Que, et al.
Published: (2024-03-01)

Unraveling the role of NLRP3 inflammasome in allergic inflammation: implications for novel therapies
by: Hui-Fei Lu, et al.
Published: (2024-07-01)

Research progress on NLRP3 inflammasomes in male reproductive immunity
by: Xue Zhang, et al.
Published: (2024-08-01)

Effects of in-ovo injection of Yu ping feng polysaccharides on growth performance, intestinal development, and immunity in broiler chickens
by: Li-Gang Xue, et al.
Published: (2025-01-01)

The important role of NLRP6 inflammasome in Pasteurella multocida infection
by: Xingping Wu, et al.
Published: (2022-10-01)

The NLRP3 inflammasome: contributions to inflammation-related diseases
by: Ying Chen, et al.
Published: (2023-06-01)

Effect of NLRP3 inflammasome on cerebral ischemia-reperfusion
by: GUO Yan-qin, YIN Bo-kai, ZHANG Juan, HE Zhi
Published: (2021-01-01)

Progress of NLRP3 inflammasome in the pathogenesis of heart disease
by: GAO Yuan, ZHENG Gang, QI Jing, ZHANG Feng
Published: (2023-07-01)

A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases
by: Callum AH Docherty, et al.
Published: (2023-01-01)

Gastrodin improves neuroinflammation-induced cognitive dysfunction in rats by regulating NLRP3 inflammasome
by: Xue Zheng, et al.
Published: (2022-12-01)

Chalcone: A potential scaffold for NLRP3 inflammasome inhibitors
by: Pritam Thapa, et al.
Published: (2023-04-01)

Research progress of NLRP3 inflammasome in the pathogenesis of psoriasis
by: Siman SHI, et al.
Published: (2022-10-01)

NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
by: Wan Z, et al.
Published: (2019-09-01)

NLRP3 inflammasome: The rising star in cardiovascular diseases
by: Yidan Zheng, et al.
Published: (2022-09-01)

Role of NLRP3 inflammasome in central nervous system diseases
by: Lu Zhang, et al.
Published: (2024-06-01)

New insight into the role of the pathway NLRP1 and NLRP3 inflammasomes and IL-33 in ultraviolet-induced cutaneous carcinogenesis
by: Aleksandra Lesiak, et al.
Published: (2025-01-01)

Research progress on the role of NLRP3 inflammasome in the treatment of ischemia-reperfusion injury
by: LU Yapeng, XIE Jianqin
Published: (2023-04-01)

The Roles of Endoplasmic Reticulum in NLRP3 Inflammasome Activation
by: Yang Zhou, et al.
Published: (2020-05-01)

The role of NLRP3 inflammasome in type 2 inflammation related diseases
by: Shenming Xu, et al.
Published: (2024-12-01)

The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases
by: Burak Ibrahim Arioz, et al.
Published: (2021-06-01)

The Role of NLRP3 Inflammasome Signaling on Arrhythmias in Diabetes
by: Zhang L, et al.
Published: (2022-12-01)

The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy
by: Xiaoqin Zheng, et al.
Published: (2023-04-01)

Inhibiting the NLRP3 Inflammasome
by: Lina Y. El-Sharkawy, et al.
Published: (2020-11-01)

The Expression and Significance of NLRP3 Inflammasome in Patients with Primary Glomerular Diseases
by: Jing Xiong, et al.
Published: (2015-06-01)